The financing round was led by Lunar Ventures to support product commercialisation and clinical development.
"Menstruation is known as the fifth vital sign, but has historically been overlooked by the wearable sector, leaving millions without the data they need to understand and advocate for their own bodies. We envision a future where menstrual health is measured and understood as comprehensively as cardiovascular or metabolic health, giving people access to objective, actionable insights to better manage their health and wellbeing."
The bridging round was led by British Design Fund to support global growth for the medical device innovator.
"This investment reflects strong support for our mission to improve patient safety worldwide. We’re encouraged by the growing interest in DoubleCHEK and remain focused on expanding access to safer enteral technologies."
The Birmingham-based health-tech firm has raised new capital from venture backers to scale its personalised nutrition brand.
"This latest round marks a huge milestone not just for Rem3dy Health, but for the Midlands innovation scene. Both Borski and Future Planet Capital share our belief that world-class innovation doesn’t have to start – or stay – in London. This investment proves that regional founders can raise global capital and scale globally from right here in Birmingham."
The UK healthtech firm won the funding as part of the 43North startup competition and the People's Choice Award.
"We are so proud to have received the recent funding from 43North, and to have also been recognised by the Buffalo community for the People's Choice Award."
The seed round was led by Paul Graham to support the development of scalable quantum infrastructure.
"With strong investor backing and a leadership team rooted in deep technical and commercial expertise. I am thrilled to be leading QFX delivering quantum hardware which will enable the next generation of quantum systems."
